申请人:Novartis Corporation
公开号:US05719141A1
公开(公告)日:1998-02-17
Compounds of the formula I ##STR1## in which R.sub.1 is arylamino, N-aryl-N-(lower alkoxy-lower alkyl)-amino, N-aryl-N-aryl-lower alkyl-amino or heterocyclyl bonded via a ring carbon atom, X is a carbonyl or methylene group, R.sub.2 and R.sub.3 independently of one another are hydrogen or lower alkyl or, together with the carbon atom with which they are bonded, are a cycloalkylidene radical, R.sub.4 is hydrogen, lower alkyl, lower alkanoyl or lower alkoxycarbonyl, R.sub.5 is hydroxyl, lower alkanoyloxy or lower alkoxycarbonyloxy, R.sub.6 is hydrogen, lower alkyl, lower alkenyl, lower alkynyl, cycloalkyl, cycloalkyl-lower alkyl, aryl-lower alkyl or heteroaryl-lower alkyl having 5 to 7 ring atoms in the heteroaryl ring and R.sub.7 is hydrogen or lower alkyl, or R.sub.6 and R.sub.7, together with the carbon atom with which they are bonded, are a cydoalkylidene radical and R.sub.8 denotes an aliphatic, cycloaliphatic-aliphatic or heteroarylaliphatic radical, and their salts can be used as active ingredients for medicaments for treatment of high blood pressure.
公式I的化合物##STR1##中,其中R.sub.1是芳基氨基,N-芳基-N-(较低烷氧基-较低烷基)-氨基,N-芳基-N-芳基-较低烷基-氨基或通过环碳原子连接的杂环基,X是羰基或亚甲基基团,R.sub.2和R.sub.3彼此独立地是氢或较低烷基,或者与它们连接的碳原子一起是环烷基亚甲基基团,R.sub.4是氢,较低烷基,较低烷酰基或较低烷氧羰基,R.sub.5是羟基,较低烷酰氧基或较低烷氧羰氧基,R.sub.6是氢,较低烷基,较低烯基,较低炔基,环烷基,环烷基-较低烷基,芳基-较低烷基或杂环芳基-较低烷基,在杂环芳基环中有5到7个环原子,R.sub.7是氢或较低烷基,或者R.sub.6和R.sub.7与它们连接的碳原子一起是环烷基亚甲基基团,R.sub.8表示脂肪,环脂肪-脂肪或杂环脂肪基团,它们的盐可用作治疗高血压药物的活性成分。